MDA MDA
Company Profile ↓Company Overview
MDA (MDA) is a publicly traded company listed on with a market capitalization of $4.29B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 60.4% per year over the last five years.
Revenue has grown at a 36.6% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.30.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.63B (+51.2% YoY); net profit $108.50M.
- Trailing 12 Months Year-on-year growth — revenue +51.2%, earnings +36.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 36.6%, profit CAGR 60.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 36.57% |
| 1 Year: | 51.21% |
Compounded Profit Growth
| 5 Years: | 60.38% |
| 1 Year: | 36.65% |
Stock Price Performance
| 1 Year: | +10.19% |
| 6 Months: | - |
| 3 Months: | +11.24% |
| 1 Month: | -14.14% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)52.24 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 36.6% over 5 years.
- Profit CAGR of 60.4% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 30.3% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 351.00M | 373.30M | 409.80M | 499.10M | 464.10M |
| Cost of Revenue | - | 271.30M | 278.50M | 301.70M | 372.00M | 348.90M |
| Gross Profit | - | 79.70M | 94.80M | 108.10M | 127.10M | 115.20M |
| Operating Expenses | - | 44.40M | 51.20M | 75.00M | 81.30M | 75.10M |
| Operating Income | - | 35.30M | 43.60M | 33.10M | 45.80M | 40.10M |
| EBITDA | - | 75.50M | 64.30M | 87.80M | 82.40M | 78.10M |
| Interest Expense | - | 4.90M | 2.90M | 5.60M | 3.60M | 6.40M |
| Pretax Income | - | 45.30M | 35.80M | 38.80M | 32.50M | 41.20M |
| Tax Provision | - | 12.40M | 8.60M | 14.40M | 8.50M | 11.60M |
| Net Income | - | 32.90M | 27.20M | 24.40M | 24.00M | 29.60M |
| Diluted EPS | - | 0.26 | 0.21 | 0.19 | - | 0.21 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 641.20M | 807.60M | 1.08B | 1.63B |
| Cost of Revenue | - | 412.80M | 563.60M | 798.40M | 1.22B |
| Gross Profit | - | 228.40M | 244.00M | 281.70M | 409.70M |
| Operating Expenses | - | 153.80M | 166.50M | 174.90M | 251.90M |
| Operating Income | - | 74.60M | 77.50M | 106.80M | 157.80M |
| EBITDA | - | 123.90M | 154.00M | 230.00M | 310.00M |
| Interest Expense | - | 13.50M | 8.60M | 28.00M | 17.00M |
| Pretax Income | - | 34.20M | 67.30M | 111.00M | 152.40M |
| Tax Provision | - | 7.90M | 18.50M | 31.60M | 43.90M |
| Net Income | - | 26.30M | 48.80M | 79.40M | 108.50M |
| Diluted EPS | - | 0.21 | 0.40 | 0.63 | 0.84 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.75B | 2.16B | 2.60B | 3.36B |
| Current Assets | - | 378.20M | 456.60M | 626.50M | 614.50M |
| Cash & Equivalents | - | 39.30M | 22.50M | 166.70M | 152.00M |
| Inventory | - | 7.50M | 9.90M | 8.10M | 23.50M |
| Receivables | - | 148.00M | 144.10M | 71.00M | 85.50M |
| Total Liabilities | - | 750.20M | 1.10B | 1.42B | 2.00B |
| Current Liabilities | - | 318.60M | 373.20M | 1.09B | 1.32B |
| Long Term Debt | 144.70M | 243.60M | 438.90M | - | 272.00M |
| Total Debt | - | 251.90M | 525.00M | 136.80M | 411.10M |
| Total Equity | - | 1.00B | 1.06B | 1.18B | 1.35B |
| Shares Outstanding | - | 119.01M | 119.51M | 121.53M | 126.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 57.00M | 13.50M | 812.70M | 407.50M |
| Investing Cash Flow | - | -180.10M | -217.60M | -227.00M | -614.60M |
| Financing Cash Flow | - | 78.80M | 187.40M | -436.10M | 196.30M |
| Capital Expenditure | - | -180.10M | -193.20M | -204.90M | -275.40M |
| Free Cash Flow | - | -123.10M | -179.70M | 607.80M | 132.10M |
| Net Change in Cash | - | -44.30M | -16.70M | 149.60M | -10.80M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 35.6% | 30.2% | 26.1% | 25.1% |
| Operating Margin % | - | 11.6% | 9.6% | 9.9% | 9.7% |
| Net Margin % | - | 4.1% | 6.0% | 7.4% | 6.6% |
| ROE % | - | 2.6% | 4.6% | 6.8% | 8.0% |
| ROCE % | - | 5.2% | 4.3% | 7.1% | 7.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MDA
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTFBjOVJReS0tUUVrLWZabmtuYkFlZEtkN2VsemczUGNIMzFqRGRYRzByejdoSjgwR1lUcWpKMVI5S2c5M3JfMmxzeTE5SElmRGs?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <font…
C$600M debt: MDA Space (MDA) funds planned Blue Canyon deal - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQaUtLUzkxNUk0QndYYjRLdFF5cFVhMGJSVlgtRklVSkFkX19jT19Hamthc0lpV1UyR1JMWVdDMTZ6WjNIa1h3UWtFYjl3X3BpS1BoN21wQUh0dkNrYTRpZE00ajhBREZUQW1KNndGM1k3eExOS0lZdGxzY0x4bG5taVpGM0p4NEVXZEpicW…
MDA Space (TSX:MDA) Lands Expanded Telesat Role As Its Undervalued Narrative Gets Tested - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxPWGNaaHBaSTk0Sk1tY0FXVnBLUFJBSXVZSW55OTBOd0VCNE93Wmpqemhvdl9JOWRWY3ZYd2FGOWJPck5FdUQyeUhqSUVNR1V1RG0zdjRQR3FZUDY2blJEalc0NUV4ZEtHN0xjVzhTM3BKRWRWa2VSc1RzMW1iTmVOQUJUUUdiX1FCMzk3U2…
MDA Space Ltd. expected to post earnings of 36 cents a share - Earnings Preview - TradingView
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQeHR1ZnBUSEI1OF96NHNQbDVjZUhwR0xDeDFySzRETzlQRXlVX296ZlYxaUtreC1ZOHpIeEVENlhycXJiME45UmQ4X3BUbUJKTVZGSU1rTEQ1UFowdmFhcEdhZTdMdl9MZTZDWUR6RGw0dzFFazNoMlRaQ3FRUG5NQkNlQm9yUFkydG5rVn…
Is MDA Space Ltd. (MDA) A Good Stock To Buy Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNdkJxQ0o1UG9teWRCSl9pX1dxVExWLVhaLXlxUW1tNHh0Mm5wTmFvV25HcGJyNGhYdFZJTzFWLS1hMHRpYmJVTjJfOTdlSXQtTHRuNWR0REk5dWpnMEY2cnM5MG93TGJNdEs3ZmtMOGpxVk01QVZLWU5keV9WZ3VmNUhiSFRLdnFTel8taE…
MDA Space stock surges on $474M Telesat satellite contract - Investing.com
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPUUJ5VF9DTk1OSEhYaFVPU1FKM3pvb3d5ZU15MHhzSVF3ZVdJR0d4RFRFcnpyNlRvcGJsYl9fOHpVa1hDd2pLQTk2Y0lYNFZOeVpUTnE4LUt3VS11NGJGUFVUa25DN1pYVEVrREI1WmM4R0VweGZBTGdIR1ZqMVVVTUN3aFpVdHRxY2I5dF…
MDA — Frequently Asked Questions
What is the current share price of MDA?
As of 2026-08-05 17:25 PDT, MDA trades at $33.94 on NASDAQ/NYSE. Its 52-week range is $23.61 to $48.68.
What is the market capitalisation of MDA?
MDA has a market capitalisation of $4.29B on NASDAQ/NYSE.
What is the P/E ratio of MDA?
MDA trades at a trailing price-to-earnings (P/E) ratio of 40.40. Its price-to-book (P/B) ratio is 3.16.
What is the return on equity (ROE) of MDA?
MDA has a return on equity (ROE) of 8.01%. Its return on capital employed (ROCE) is 7.74%.
Is MDA a good stock to buy?
This page provides a data-driven analysis of MDA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.